Chapter 4. Introduction to Anticancer Therapeutics

  1. Sotiris Missailidis
  1. Teni Boulikas

Published Online: 7 NOV 2008

DOI: 10.1002/9780470697047.ch4

Anticancer Therapeutics

Anticancer Therapeutics

How to Cite

Boulikas, T. (2008) Introduction to Anticancer Therapeutics, in Anticancer Therapeutics (ed S. Missailidis), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9780470697047.ch4

Editor Information

  1. Department of Chemistry and Analytical Sciences, The Open University, Milton Keynes, UK

Author Information

  1. Regulon Inc. (USA), Afxentiou 7, Alimos, Athens, Greece

Publication History

  1. Published Online: 7 NOV 2008
  2. Published Print: 21 NOV 2008

ISBN Information

Print ISBN: 9780470723036

Online ISBN: 9780470697047



  • cancer biology problems;
  • anticancer therapeutics;
  • tarceva and endothelial growth factor receptor (EGFR) inhibitor;
  • proteins and RNAi (inhibitory RNA) - gene therapy targets;
  • cancer problems and unmet needs;
  • chemotherapy drug classification;
  • cancer and existing and emerging biological therapies;
  • vascular endothelial growth factor (bevacizumab) or EGFR (cetuximab)


This chapter contains sections titled:

  • Problems in cancer

  • Cancer treatments

  • Classification of chemotherapy drugs